By proceeding, you agree to our Terms of Use and Privacy Policy.
Welcome to the Inaugural RNA Assay Development & Screening Summit 2023! This groundbreaking event is designed to revolutionize RNA drug discovery by providing drug developers with robust assays and screening tools.At the RNA Assay Development & Screening Summit, we understand the challenges faced by drug developers when it comes to developing effective RNA assays and screening tools. Our forum is dedicated to addressing these challenges head-on and providing actionable solutions for efficient drug discovery.Developed in collaboration with industry experts, this summit brings together key opinion leaders who will share their technical expertise and present data-driven case studies. These insights will equip attendees with the knowledge and tools to overcome hurdles in in-house assay development and screening strategies. The focus will be on identifying new RNA targets and understanding their biological effects, enabling the progression from early discovery to drug candidate selection.With over 60 experts in attendance, representing various disciplines such as assay development, screening, pharmacology, and lead discovery, this summit offers an unparalleled opportunity for networking and interactive learning. Engage with like-minded professionals, expand your knowledge through exciting data presentations, and participate in learning sessions that will validate and enhance your assay and screening strategies.Our goal is to supercharge your RNA drug discovery efforts by providing you with the latest advancements in assay development and screening techniques. By attending this summit, you will gain valuable insights, forge new connections, and accelerate the path to the clinic.Don't miss out on this exclusive opportunity to be part of the inaugural RNA Assay Development & Screening Summit.
Uncover the new developments and advancements in RNA assays and screening tools.
Explore screening strategies to find new RNA targets and determine biological effects that support the progression from early discovery to the drug candidate.
Engage in exclusive sessions and discussions led by top experts to expand and validate your assay and screening strategies to accelerate the path to the clinic.
Immerse yourself in the innovative world of RNA research, witness groundbreaking discoveries, and explore the advancement of RNA-based therapeutics.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Eclipsebio has developed multiple world-class RNA genomics products used by biopharma and academic customers around the world to map their RNA targets and RNA binding proteins with unmatched clarity.
Depixus (formerly PicoSeq) is undertaking commercial development of a disruptive new technology for the fast, accurate, and inexpensive extraction of sequence and epigenetic information from long individual molecules of DNA and RNA. Our MAGNA technol
Depixus (formerly PicoSeq) is undertaking commercial development of a disruptive new technology for the fast, accurate, and inexpensive extraction of sequence and epigenetic information from long individual molecules of DNA and RNA. Our MAGNA technology goes beyond decoding the static genetic code t
Momentum Biotechnologies (“Momentum”) is a specialized CRO focused on providing mass spectrometry-based native detection technologies for lead discovery and the quantification of difficult targets to biopharmaceutical clients globally. We are the lea
Momentum Biotechnologies (“Momentum”) is a specialized CRO focused on providing mass spectrometry-based native detection technologies for lead discovery and the quantification of difficult targets to biopharmaceutical clients globally. We are the leading provider of solution phase Affinity Selection
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.